To further enhance the Basser Center's mission, the Basser Global Prize was established by Shari Basser Potter and Leonard Potter to honor a visionary scientist who has conceptually advanced BRCA1/2-related research that has led to improvements in clinical care. The prize will be considered for a broad range of basic, translational and clinical BRCA1/2 cancer researchers worldwide. Outstanding candidates will be those whose research has produced seminal advances in the field and who continue to drive BRCA1/2-related research towards the ultimate goal of mitigating the adverse impact of deleteriousBRCA1/2 and related mutations.
The Basser Global Prize provides $100,000 in unrestricted support of the awardee's innovative BRCA1/2 related research efforts. The Awardee will give the Keynote address at the annual Basser Center for BRCA Symposium the following year, at which time they will be awarded the Basser trophy and a personal $10,000 cash prize by the Gray and Potter Families.
The Basser Global Prize Application Process
The nomination period for 2016 is now closed. Please check back in spring of 2017.
Nominees are not restricted to any geographic area or type of institution. The appropriate Institutional Official (e.g. Chancellor, Dean or Provost) must nominate applicants. Self-nominations will not be accepted.
The following must be included in the nomination package:
- Basser Global Prize Application Form including:
- Nominee and Institutional Official contact information and signatures
- Summary Statement of Major Research Accomplishments (500 words maximum). This statement should summarize and succinctly state the major research accomplishments of the nominee, with a particular emphasis on how these findings have advanced BRCA1/2 related research. Accomplishments can span basic biology, diagnosis, treatment and outcomes for BRCA1/2 carriers and their families.
- Listing of five most important publications related to BRCA1/2 research (250 words maximum, each). Provide a description of the importance of each publication.
- Vision for future BRCA1/2 research (1,000 words maximum). The Nominee will describe a broad vision of her/his research program over the next 5 years.
- Nominee's CV
- Nominating letter (1 page). The Institutional Official will describe the major accomplishments of the nominee and why this individual warrants consideration for the Basser Global Prize.
The completed nomination package should be sent as a PDF, preferably with all sections combined into one document, via email attachment to BasserInfo@uphs.upenn.edu. Receipt of nominations will be confirmed via email.
Previous Global Prize Winners
The winner of the 2016 Basser Global Prize is cancer geneticist Steven Narod, MD, FRCPC, PhD (hon), FRSC, director of the Familial Breast Cancer Research Unit and a senior scientist at the Women’s College Hospital in Toronto, Ontario, Canada. Narod is a world leader in the field of breast and ovarian cancer genetics, who has made significant contributions to the knowledge of how to assess cancer risk and reduce its mortality in BRCA1 and BRCA2 mutation carriers.
2015 Global Prize Winner — Dr. David Livingston
The winner of the 2015 Basser Global Prize is Dr. David Livingston, the Emil Frei Professor of Genetics and Medicine at Harvard Medical School and Chair of the Executive Committee for Research at Harvard’s Dana Farber Cancer Institute. Dr. Livingston has greatly expanded current understanding of how mutations in BRCA1 and BRCA2 can promote cancer development. His goal is to reduce the number of cells in the breast and ovary of BRCA1 mutation-bearing women that manifest a high potential for becoming malignant. “Our objective is to eliminate them by a relatively non-toxic approach and to ensure that they do not accumulate thereafter,” Livingston explains. “If successful, such an approach has the potential to significantly reduce the likelihood of BRCA1 cancer developing in mutation-bearing women.”
2014 Global Prize Winner — Dr. Mary-Claire King
The winner of the 2014 Basser Global Prize was Dr. Mary-Claire King, from the University of Washington in Seattle. Dr. King is known worldwide for her major accomplishments in human genetics research and one of her most noteworthy achievements is the identification of the BRCA1 gene. 2014 marked the 20th anniversary of the identification of the gene. “We’re very excited to honor Dr. King’s accomplishments in BRCA-related research, particularly as this year marks twenty years since the initial cloning of the BRCA1 gene,” said Dr. Susan Domchek, MD. “The identification ofBRCA1 was the first critical step in work to improve outcomes for individuals with inherited susceptibility to breast cancer. Supporting research projects that are similarly devoted to the prevention and treatment of BRCA-related cancers is a primary mission of the Basser Center.”
2013 Global Prize Winner — Dr. Alan Ashworth
The winner of the inaugural Basser Global Prize in 2013 was Professor Alan Ashworth, FRS, Chief Executive Office of the Institute for Cancer Research (ICR) in London and head of the Gene Function team in the ICR’s Breakthrough Breast Cancer Research Centre. Professor Ashworth has been a pioneer in efforts to develop therapies to target cancer cells that contain BRCA1 and BRCA2 mutations. His lab has been instrumental in the development of PARP inhibitor therapy, drugs which have shown great promise in attacking breast, ovarian, and other cancers among individuals who carry BRCA1/2 mutations. His new research explores mechanisms of drug resistance among BRCA carriers, and the possibility of combing other agents with PARP inhibitors to maximize their effectiveness and discover new methods of treatment.